Target intelligence / Profile preview

Flavivirus non-structural protein 5 methyltransferase (NS5 MTase) (NS5 MTase)

Target
NS5 MTase
Molecular classification
Enzyme, Methyltransferase, Transferase
01

Overview

The Flavivirus non-structural protein 5 (NS5) methyltransferase is a multifunctional enzyme essential for the maturation and stability of viral mRNA (UniProt P29990). Located at the N-terminus of the large NS5 protein, it catalyzes two distinct methylation steps: N7-guanine methylation and 2'-O-ribose methylation of the viral RNA cap structure (Ray et al., 2006). These modifications are crucial for efficient viral protein translation and allow the virus to evade the host's innate immune system by mimicking cellular mRNA, thereby avoiding detection by pattern recognition receptors like RIG-I (Brecher et al., 2015). Given its highly conserved nature across the Flaviviridae family—including pathogens such as Dengue, Zika, and West Nile viruses—this enzyme is a primary target for the development of broad-spectrum antivirals (Dong et al., 2008). Therapeutic strategies typically involve small molecules that competitively inhibit the S-adenosyl-L-methionine (SAM) binding pocket or target the RNA-binding site to halt viral replication (PubChem CID 439535). However, achieving high selectivity over human host methyltransferases remains a significant challenge in drug design (Brecher et al., 2015).

Other names
NS5 N-terminal domainFlavivirus RNA methyltransferaseNS5 capping enzymeNS5-MTaseFlavivirus RNA 2'-O-methyltransferase
02

Mechanism of action

Competitive inhibition of the S-adenosyl-L-methionine (SAM) binding site or the RNA-binding site to prevent viral RNA capping, thereby inhibiting viral translation and replication (Dong et al., 2008).

03

Biological functions

Viral RNA cappingN7-guanine methylation2'-O-ribose methylationViral replicationImmune evasion
04

Disease associations

InfectionDengue feverZika virus infectionWest Nile feverYellow feverJapanese encephalitis
05

Safety considerations

Potential off-target inhibition of human host RNA methyltransferases such as RNMT (Brecher et al., 2015)Development of viral resistance through mutations in the highly conserved SAM-binding pocketSelectivity challenges due to the structural similarity of the SAM-binding site across various methyltransferases
06

Interacting drugs

Sinefungin (PubChem CID 439535)

4 more in the full profile.

07

Biomarkers

Viral RNA load (RT-qPCR)NS1 antigen levels (ELISA)Viral cap methylation status (Research)

Beyond the preview

Go deeper on Flavivirus non-structural protein 5 methyltransferase (NS5 MTase) (NS5 MTase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavivirus non-structural protein 5 methyltransferase (NS5 MTase) (NS5 MTase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call